380 related articles for article (PubMed ID: 30059164)
21. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
[TBL] [Abstract][Full Text] [Related]
22. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer.
Schlecht NF; Brandwein-Gensler M; Nuovo GJ; Li M; Dunne A; Kawachi N; Smith RV; Burk RD; Prystowsky MB
Mod Pathol; 2011 Oct; 24(10):1295-305. PubMed ID: 21572401
[TBL] [Abstract][Full Text] [Related]
23. RPRD1B is a potentially molecular target for diagnosis and prevention of human papillomavirus E6/E7 infection-induced cervical cancer: A case-control study.
Wen N; Bian L; Gon J; Meng Y
Asia Pac J Clin Oncol; 2021 Jun; 17(3):230-237. PubMed ID: 32866332
[TBL] [Abstract][Full Text] [Related]
24. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.
Jordan RC; Lingen MW; Perez-Ordonez B; He X; Pickard R; Koluder M; Jiang B; Wakely P; Xiao W; Gillison ML
Am J Surg Pathol; 2012 Jul; 36(7):945-54. PubMed ID: 22743284
[TBL] [Abstract][Full Text] [Related]
25. Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC.
Linge A; Schötz U; Löck S; Lohaus F; von Neubeck C; Gudziol V; Nowak A; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Bunea H; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Lauber K; Pigorsch S; Combs SE; Mönnich D; Zips D; Baretton GB; Buchholz F; Krause M; Belka C; Baumann M;
Radiother Oncol; 2018 Apr; 127(1):27-35. PubMed ID: 29295747
[TBL] [Abstract][Full Text] [Related]
26. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
[TBL] [Abstract][Full Text] [Related]
27. Feasibility study of a human papillomavirus E6 and E7 oncoprotein test for the diagnosis of cervical precancer and cancer.
Zhang JJ; Cao XC; Zheng XY; Wang HY; Li YW
J Int Med Res; 2018 Mar; 46(3):1033-1042. PubMed ID: 29322839
[TBL] [Abstract][Full Text] [Related]
28. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
[TBL] [Abstract][Full Text] [Related]
29. Prognostic and diagnostic validity of p16/Ki-67, HPV E6/E7 mRNA, and HPV DNA in women with ASCUS: a follow-up study.
Ren C; Zhu Y; Yang L; Zhang X; Liu L; Wang Z; Jiang D
Virol J; 2019 Nov; 16(1):143. PubMed ID: 31752941
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus 16/18 E7 viral loads predict distant metastasis in oral cavity squamous cell carcinoma.
Huang CG; Lee LA; Tsao KC; Liao CT; Yang LY; Kang CJ; Chang KP; Huang SF; Chen IH; Yang SL; Lee LY; Hsueh C; Chen TC; Lin CY; Fan KH; Chang TC; Wang HM; Ng SH; Yen TC
J Clin Virol; 2014 Oct; 61(2):230-6. PubMed ID: 25097016
[TBL] [Abstract][Full Text] [Related]
31. Double demonstration of oncogenic high risk human papilloma virus DNA and HPV-E7 protein in oral cancers.
Pannone G; Santoro A; Carinci F; Bufo P; Papagerakis SM; Rubini C; Campisi G; Giovannelli L; Contaldo M; Serpico R; Mazzotta M; Lo Muzio L
Int J Immunopathol Pharmacol; 2011; 24(2 Suppl):95-101. PubMed ID: 21781453
[TBL] [Abstract][Full Text] [Related]
32. The role of high-risk human papillomavirus infection in oral and oropharyngeal squamous cell carcinoma in non-smoking and non-drinking patients: a clinicopathological and molecular study of 46 cases.
Laco J; Vosmikova H; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Nekvindova J; Vosmik M; Cermakova E; Ryska A
Virchows Arch; 2011 Feb; 458(2):179-87. PubMed ID: 21221634
[TBL] [Abstract][Full Text] [Related]
33. Association between human papillomavirus and oral cancer: a literature review.
Shigeishi H
Int J Clin Oncol; 2023 Aug; 28(8):982-989. PubMed ID: 36929094
[TBL] [Abstract][Full Text] [Related]
34. Expression of E6/E7 mRNA from 'high risk' human papillomavirus in relation to CIN grade, viral load and p16INK4a.
Andersson S; Hansson B; Norman I; Gaberi V; Mints M; Hjerpe A; Karlsen F; Johansson B
Int J Oncol; 2006 Sep; 29(3):705-11. PubMed ID: 16865288
[TBL] [Abstract][Full Text] [Related]
35. Role of human papilloma virus in oral tongue squamous cell carcinoma.
Elango KJ; Suresh A; Erode EM; Subhadradevi L; Ravindran HK; Iyer SK; Iyer SK; Kuriakose MA
Asian Pac J Cancer Prev; 2011; 12(4):889-96. PubMed ID: 21790221
[TBL] [Abstract][Full Text] [Related]
36. Absence of high-risk HPV 16 and 18 in Chinese patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Chen XJ; Sun K; Jiang WW
Virol J; 2016 May; 13():81. PubMed ID: 27206495
[TBL] [Abstract][Full Text] [Related]
37. Uniplex E6/E7 PCR method detecting E6 or E7 genes in 39 human papillomavirus types.
Okodo M; Okayama K; Teruya K; Sasagawa T
J Med Virol; 2018 May; 90(5):981-988. PubMed ID: 29314149
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical Evaluation of E6/E7 HPV Oncoproteins Staining in Cervical Cancer.
Stiasny A; Kuhn C; Mayr D; Alexiou C; Janko C; Wiest I; Jeschke U; Kost B
Anticancer Res; 2016 Jun; 36(6):3195-8. PubMed ID: 27272848
[TBL] [Abstract][Full Text] [Related]
39. Seropositivity of HPV 16 E6 and E7 and the risk of oral cancer.
Wong GR; Ha KO; Himratul-Aznita WH; Yang YH; Wan Mustafa WM; Yuen KM; Abraham MT; Tay KK; Karen-Ng LP; Cheong SC; Zain RB
Oral Dis; 2014 Nov; 20(8):762-7. PubMed ID: 24320099
[TBL] [Abstract][Full Text] [Related]
40. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
